Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velafermin for Prevention of Oral Mucositis in HSCT
NCT00323518Phase 2Completed
- Sponsor
- CuraGen Corporation
- Start
- May 2006
- Primary completion
- Aug 2008
- Modality
- Hormones & Growth Factors
- Countries
- 1
01
Overview
A Phase 2 trial of velafermin in oral mucositis (OM), sponsored by CuraGen Corporation. Started May 2006; status: completed.
02
Drugs
velafermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00323518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323518.